MedPath

Frailty, Cognitive Function and Health-related Quality of Life in Older Adults With Advanced Chronic Kidney Disease.

Completed
Conditions
Frailty
Cognitive Impairment
CKD Stage 5
CKD Stage 4
Registration Number
NCT05705011
Lead Sponsor
Grigore T. Popa University of Medicine and Pharmacy
Brief Summary

This observational study explores the impact of cognitive impairment and frailty in older adults with advanced chronic kidney disease \].

The main question\[s\] it aims to answer are:

* What determines the time to initiate dialysis? Cognitive impairment or frailty?

* What does predict the time to death? Presence of frailty or cognitive impairment?

* What does correlate strongly with time-low health-related quality of life? frailty or cognitive impairment?

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
240
Inclusion Criteria
  • Patients age 65 years or older.
  • CKD stage 4 and 5 who were identified by two consecutive measurements of estimated glomerular filtration rate (eGFR) <30 mL/min/1.73 m2 separated by more than 3 months.
Exclusion Criteria
  • Patients younger than 65 years old.
  • Chronic kidney disease stages 1,2, and 3.
  • Dialysis dependence
  • History of kidney transplantation.
  • Initial visit with the health care provider.
  • Recent acute kidney injury.
  • Patients who had been hospitalized for more than 2 months before the visit (because long hospitalization might affect the degree of frailty)
  • Patients with myocardial infarction and cerebrovascular accident 3 months before the assessment
  • Patients who are blind or with limb amputation.
  • Patients who refuse to participate.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time to initiate dialysis.36 months

The time from the assessment moment to start dialysis of an older adult with advanced CKD (

Time to death36 months

The time from the assessment moment to death of an older adult with advanced CKD ( CKD stage 4 and 5).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Medicine and Pharmacy "Grigore T. Popa"

🇷🇴

Iasi, Romania

© Copyright 2025. All Rights Reserved by MedPath